Elidel and Tumor - a phase IV clinical study of FDA data

Summary:

Tumor is reported as a side effect among people who take Elidel (pimecrolimus), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Protopic, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Tumor when taking Elidel. It is created by eHealthMe based on reports of 5,143 people who have side effects when taking Elidel from the FDA, and is updated regularly.

What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 5,201 Elidel users. Check the latest studies of Elidel.

What is Tumor?

Tumor is found to be associated with 1,407 drugs and 1,707 conditions by eHealthMe. Check the latest studies of Tumor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,143 people reported to have side effects when taking Elidel.
Among them, 45 people (0.87%) have Tumor.

Among these 45 people:

How long have people been on Elidel when they have Tumor? *

What is the gender of people who have Tumor when taking Elidel? *

female: 61.54 %
male: 38.46 %

What is the age of people who have Tumor when taking Elidel? *

What are other drugs people take besides Elidel? *

What are other side effects people have besides Tumor? *

Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 16 people, 35.56%
Chest Pain: 16 people, 35.56%
Thrombosis (formation of a blood clot inside a blood vessel): 14 people, 31.11%
Weakness: 13 people, 28.89%
Rashes (redness): 13 people, 28.89%
Hair Loss: 11 people, 24.44%
Fatigue (feeling of tiredness): 11 people, 24.44%
Dizziness: 11 people, 24.44%
Allergic Rhinitis: 11 people, 24.44%
Cellulitis (infection under the skin): 9 people, 20.00%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 5 people, 11.11%
Vitiligo (pigment is lost from areas of the skin): 4 people, 8.89%
Stress And Anxiety: 4 people, 8.89%
Metastases To Bone (cancer spreads to bone): 2 people, 4.44%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 2.22%
Pityriasis Rosea (itchy rash develops over the trunk and extremities): 1 person, 2.22%
Neuropathy Peripheral (surface nerve damage): 1 person, 2.22%
Muscle Spasms (muscle contraction): 1 person, 2.22%
High Blood Pressure: 1 person, 2.22%
Hidradenitis (chronic disease of a type of sweat gland): 1 person, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and have Tumor?

- Check whether Tumor is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elidel:

Elidel (5,201 reports)

Tumor treatments and more:

Tumor (38,734 reports)

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tumor:

Tumor (1,407 drugs)

Browse all the conditions that are associated with Tumor:

Tumor (1,707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus (the active ingredients of Elidel) and Elidel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.